Kenvue (KVUE) Financials

$21.37 -0.39 (-1.79%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$21.37 0.00 (0.00%)

As of 08/8/2025 07:59 PM Eastern

Annual Income Statements for Kenvue

This table shows Kenvue's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Net Income / (Loss) Attributable to Common Shareholders	2,078	2,064	1,664	1,030
Consolidated Net Income / (Loss)	2,078	2,064	1,664	1,030
Net Income / (Loss) Continuing Operations	2,078	2,064	1,664	1,030
Total Pre-Tax Income	2,925	2,637	2,190	1,415
Total Operating Income	2,920	2,675	2,512	1,841
Total Gross Profit	8,419	8,285	8,643	8,959
Total Revenue	15,054	14,950	15,444	15,455
Operating Revenue	15,054	14,950	15,444	15,455
Total Cost of Revenue	6,635	6,665	6,801	6,496
Operating Cost of Revenue	6,635	6,665	6,801	6,496
Total Operating Expenses	5,499	5,610	6,131	7,118
Selling, General & Admin Expense	5,484	5,633	6,141	6,329
Other Operating Expenses / (Income)	15	-35	-10	26
Impairment Charge	-	12	0.00	578
Restructuring Charge	-	0.00	0.00	185
Total Other Income / (Expense), net	5.00	-38	-322	-426
Interest & Investment Income	-	0.00	-250	-378
Other Income / (Expense), net	5.00	-38	-72	-48
Income Tax Expense	847	573	526	385
Basic Earnings per Share	$1.21	$1.20	$0.90	$0.54
Weighted Average Basic Shares Outstanding	1.72B	1.72B	1.85B	1.92B
Diluted Earnings per Share	$1.21	$1.20	$0.90	$0.54
Weighted Average Diluted Shares Outstanding	1.72B	1.72B	1.85B	1.92B
Weighted Average Basic & Diluted Shares Outstanding	-	-	1.91B	1.91B

This table shows Kenvue's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025
Net Income / (Loss) Attributable to Common Shareholders	-	469	430	438	327	296	58	383	293	322	420
Consolidated Net Income / (Loss)	-	469	430	438	327	296	58	383	293	322	420
Net Income / (Loss) Continuing Operations	-	469	430	438	327	296	58	383	293	322	420
Total Pre-Tax Income	-	609	639	585	357	427	65	577	346	458	588
Total Operating Income	-	640	702	710	460	550	154	654	483	558	692
Total Gross Profit	-	2,125	2,225	2,250	2,043	2,242	2,365	2,282	2,070	2,168	2,261
Total Revenue	-	3,852	4,011	3,915	3,666	3,894	4,000	3,899	3,662	3,741	3,839
Operating Revenue	-	3,852	4,011	3,915	3,666	3,894	4,000	3,899	3,662	3,741	3,839
Total Cost of Revenue	-	1,727	1,786	1,665	1,623	1,652	1,635	1,617	1,592	1,573	1,578
Operating Cost of Revenue	-	1,727	1,786	1,665	1,623	1,652	1,635	1,617	1,592	1,573	1,578
Total Operating Expenses	-	1,485	1,523	1,540	1,583	1,692	2,211	1,628	1,587	1,610	1,569
Selling, General & Admin Expense	-	1,502	1,522	1,531	1,586	1,573	1,641	1,590	1,525	1,537	1,504
Other Operating Expenses / (Income)	-	-17	1.00	9.00	-3.00	10	12	7.00	-71	13	5.00
Impairment Charge	-	-	0.00	0.00	-	68	510	0.00	-	0.00	0.00
Restructuring Charge	-	0.00	0.00	0.00	-	41	48	31	65	60	60
Total Other Income / (Expense), net	-	-31	-63	-125	-103	-123	-89	-77	-137	-100	-104
Interest & Investment Income	-	-	-53	-100	-	-95	-92	-96	-	-94	-94
Other Income / (Expense), net	-	-30	-10	-25	-7.00	-28	3.00	19	-42	-6.00	-10
Income Tax Expense	-	140	209	147	30	131	7.00	194	53	136	168
Basic Earnings per Share	-	$0.27	$0.23	$0.23	$0.17	$0.15	$0.03	$0.20	$0.16	$0.17	$0.22
Weighted Average Basic Shares Outstanding	1.72B	1.72B	1.84B	1.92B	1.85B	1.92B	1.92B	1.92B	1.92B	1.91B	1.92B
Diluted Earnings per Share	-	$0.27	$0.23	$0.23	$0.17	$0.15	$0.03	$0.20	$0.16	$0.17	$0.22
Weighted Average Diluted Shares Outstanding	1.72B	1.72B	1.84B	1.92B	1.85B	1.92B	1.92B	1.92B	1.92B	1.93B	1.93B
Weighted Average Basic & Diluted Shares Outstanding	0.00	-	-	1.91B	1.91B	1.91B	1.92B	1.92B	1.91B	1.92B	1.92B

This table details how cash moves in and out of Kenvue's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Net Change in Cash & Equivalents	122	491	151	-312
Net Cash From Operating Activities	334	2,525	3,168	1,769
Net Cash From Continuing Operating Activities	334	2,525	3,168	1,769
Net Income / (Loss) Continuing Operations	2,078	2,064	1,664	1,030
Consolidated Net Income / (Loss)	2,078	2,064	1,664	1,030
Depreciation Expense	731	644	627	622
Non-Cash Adjustments To Reconcile Net Income	136	162	194	973
Changes in Operating Assets and Liabilities, net	-2,611	-345	683	-856
Net Cash From Investing Activities	-171	-390	-488	-425
Net Cash From Continuing Investing Activities	-171	-390	-488	-425
Purchase of Property, Plant & Equipment	-295	-375	-469	-434
Sale and/or Maturity of Investments	0.00	0.00	8,941	0.00
Other Investing Activities, net	47	-15	-8,960	9.00
Net Cash From Financing Activities	0.00	-1,583	-2,527	-1,565
Net Cash From Continuing Financing Activities	0.00	-1,583	-2,527	-1,565
Repayment of Debt	-7.00	14	-193	65
Repurchase of Common Equity	-	0.00	-7.00	-235
Payment of Dividends	0.00	0.00	-766	-1,552
Issuance of Debt	0.00	0.00	8,260	157
Issuance of Common Equity	0.00	0.00	4,241	0.00
Other Financing Activities, net	7.00	-1,597	-14,062	0.00
Effect of Exchange Rate Changes	-41	-61	-2.00	-91
Cash Interest Paid	0.00	0.00	224	439
Cash Income Taxes Paid	363	316	699	810

This table details how cash moves in and out of Kenvue's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025
Net Change in Cash & Equivalents	434	8,155	-8,155	-169	320	-227	-141	43	13	-13	13
Net Cash From Operating Activities	644	802	742	674	950	287	440	249	793	428	621
Net Cash From Continuing Operating Activities	644	802	742	674	950	287	440	249	793	428	621
Net Income / (Loss) Continuing Operations	361	469	430	438	327	296	58	383	293	322	420
Consolidated Net Income / (Loss)	361	469	430	438	327	296	58	383	293	322	420
Depreciation Expense	166	152	148	153	174	149	141	182	150	136	142
Non-Cash Adjustments To Reconcile Net Income	48	35	50	-21	130	185	585	75	128	60	54
Changes in Operating Assets and Liabilities, net	69	146	114	104	319	-343	-344	-391	222	-90	5.00
Net Cash From Investing Activities	-167	-41	-77	-105	-265	-152	-85	-56	-132	-167	-90
Net Cash From Continuing Investing Activities	-167	-41	-77	-105	-265	-152	-85	-56	-132	-167	-90
Purchase of Property, Plant & Equipment	-159	-55	-77	-114	-223	-153	-90	-59	-132	-179	-88
Other Investing Activities, net	-	0.00	-8,941	9.00	-28	1.00	5.00	3.00	-	12	-2.00
Net Cash From Financing Activities	-63	7,388	-8,806	-726	-383	-326	-490	-162	-587	-310	-548
Net Cash From Continuing Financing Activities	-63	7,388	-8,806	-726	-383	-326	-490	-162	-587	-310	-548
Repayment of Debt	-8.00	-12	-13	-98	-70	-12	3.00	46	28	-723	56
Repurchase of Common Equity	-	0.00	-	-	-7.00	-91	-	-23	-121	-63	-64
Payment of Dividends	1,542	0.00	-	-383	-383	-383	-383	-393	-393	-392	-393
Issuance of Debt	-	7,686	742	-245	77	160	-110	208	-101	868	-147

This table presents Kenvue's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	1/1/2023	12/31/2023	12/29/2024
Total Assets	27,316	27,851	25,601
Total Current Assets	5,877	6,138	5,525
Cash & Equivalents	1,231	1,382	1,070
Accounts Receivable	2,122	2,073	2,165
Inventories, net	2,226	1,851	1,591
Prepaid Expenses	175	567	494
Other Current Assets	123	265	205
Plant, Property, & Equipment, net	1,820	2,042	1,849
Total Noncurrent Assets	19,619	19,671	18,227
Goodwill	9,185	9,271	8,843
Intangible Assets	9,853	9,619	8,474
Noncurrent Deferred & Refundable Income Taxes	147	158	184
Other Noncurrent Operating Assets	434	623	726
Total Liabilities & Shareholders' Equity	27,316	27,851	25,601
Total Liabilities	7,346	16,640	15,933
Total Current Liabilities	3,926	5,481	5,739
Short-Term Debt	0.00	599	1,552
Accounts Payable	1,829	2,489	2,254
Accrued Expenses	1,768	2,251	1,859
Current Deferred & Payable Income Tax Liabilities	329	142	74
Total Noncurrent Liabilities	3,420	11,159	10,194
Long-Term Debt	0.00	7,687	7,055
Noncurrent Deferred & Payable Income Tax Liabilities	2,479	2,621	2,261
Noncurrent Employee Benefit Liabilities	214	360	342
Other Noncurrent Operating Liabilities	727	491	536
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	19,970	11,211	9,668
Total Preferred & Common Equity	19,970	11,211	9,668
Preferred Stock	0.00	0.00	0.00
Total Common Equity	19,970	11,211	9,668
Common Stock	0.00	16,166	16,149
Retained Earnings	0.00	429	-93
Treasury Stock	0.00	-7.00	-242
Accumulated Other Comprehensive Income / (Loss)	-5,455	-5,377	-6,146

This table presents Kenvue's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	1/1/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025
Total Assets	27,316	27,077	27,851	27,283	26,443	26,925	25,601	26,257	27,132
Total Current Assets	5,877	5,894	6,138	6,097	5,881	5,941	5,525	5,710	5,854
Cash & Equivalents	1,231	1,062	1,382	1,155	1,014	1,057	1,070	1,057	1,070
Accounts Receivable	2,122	2,109	2,073	2,160	2,240	2,394	2,165	2,312	2,331
Inventories, net	2,226	1,885	1,851	1,884	1,849	1,820	1,591	1,680	1,776
Prepaid Expenses	175	619	567	645	557	460	494	505	525
Other Current Assets	123	219	265	253	221	210	205	156	152
Plant, Property, & Equipment, net	1,820	1,872	2,042	2,005	2,004	1,776	1,849	1,927	2,038
Total Noncurrent Assets	19,619	19,311	19,671	19,181	18,558	19,208	18,227	18,620	19,240
Goodwill	9,185	8,974	9,271	9,032	8,973	9,297	8,843	9,136	9,486
Intangible Assets	9,853	9,487	9,619	9,378	8,762	8,887	8,474	8,586	8,804
Noncurrent Deferred & Refundable Income Taxes	147	156	158	171	206	228	184	199	220
Other Noncurrent Operating Assets	434	694	623	600	617	796	726	699	730
Total Liabilities & Shareholders' Equity	27,316	27,077	27,851	27,283	26,443	26,925	25,601	26,257	27,132
Total Liabilities	7,346	16,184	16,640	16,662	16,265	16,281	15,933	16,204	16,402
Total Current Liabilities	3,926	5,161	5,481	6,166	5,937	5,946	5,739	6,666	5,988
Short-Term Debt	0.00	513	599	1,522	1,427	1,648	1,552	2,429	1,553
Accounts Payable	1,829	2,281	2,489	2,602	2,437	2,274	2,254	2,332	2,568
Accrued Expenses	1,768	1,984	2,251	1,878	1,977	1,861	1,859	1,751	1,778
Current Deferred & Payable Income Tax Liabilities	329	383	142	164	96	163	74	154	89
Total Noncurrent Liabilities	3,420	11,023	11,159	10,496	10,328	10,335	10,194	9,538	10,414
Long-Term Debt	0.00	7,685	7,687	7,033	7,051	7,053	7,055	6,309	7,057
Noncurrent Deferred & Payable Income Tax Liabilities	2,479	2,515	2,621	2,568	2,392	2,378	2,261	2,320	2,380
Noncurrent Employee Benefit Liabilities	214	254	360	354	350	362	342	350	371
Other Noncurrent Operating Liabilities	727	569	491	541	535	542	536	559	606
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	19,970	10,893	11,211	10,621	10,178	10,644	9,668	10,053	10,730
Total Preferred & Common Equity	19,970	10,893	11,211	10,621	10,178	10,644	9,668	10,053	10,730
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	19,970	10,893	11,211	10,621	10,183	10,644	9,668	10,053	10,730
Common Stock	0.00	16,150	16,166	16,052	16,094	16,117	16,149	16,220	16,307
Retained Earnings	0.00	485	429	342	17	7.00	-93	-163	-136
Treasury Stock	0.00	-	-7.00	-98	-93	-121	-242	-305	-369
Accumulated Other Comprehensive Income / (Loss)	-5,455	-5,742	-5,377	-5,675	-5,835	-5,359	-6,146	-5,699	-5,072

This table displays calculated financial ratios and metrics derived from Kenvue's official financial filings.

Metric	2021	2022	2023	2024
Period end date	1/2/2022	1/1/2023	12/31/2023	12/29/2024
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	-0.69%	3.30%	0.07%
EBITDA Growth	0.00%	-10.26%	-6.52%	-21.26%
EBIT Growth	0.00%	-9.85%	-7.47%	-26.52%
NOPAT Growth	0.00%	0.93%	-8.84%	-29.79%
Net Income Growth	0.00%	-0.67%	-19.38%	-38.10%
EPS Growth	0.00%	-0.83%	-25.00%	-40.00%
Operating Cash Flow Growth	0.00%	655.99%	25.47%	-44.16%
Free Cash Flow Firm Growth	0.00%	0.00%	115.22%	-11.16%
Invested Capital Growth	0.00%	0.00%	-3.33%	-5.02%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-0.03%
EBITDA Q/Q Growth	0.00%	0.00%	395.48%	-1.47%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-0.66%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-1.21%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-3.20%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-1.82%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	10.69%	-8.15%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	105.02%
Invested Capital Q/Q Growth	0.00%	0.00%	0.48%	-5.92%
Profitability Metrics	-	-	-	-
Gross Margin	55.93%	55.42%	55.96%	57.97%
EBITDA Margin	24.29%	21.95%	19.86%	15.63%
Operating Margin	19.40%	17.89%	16.27%	11.91%
EBIT Margin	19.43%	17.64%	15.80%	11.60%
Profit (Net Income) Margin	13.80%	13.81%	10.77%	6.66%
Tax Burden Percent	71.04%	78.27%	75.98%	72.79%
Interest Burden Percent	100.00%	100.00%	89.75%	78.92%
Effective Tax Rate	28.96%	21.73%	24.02%	27.21%
Return on Invested Capital (ROIC)	0.00%	22.35%	10.36%	7.59%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	27.18%	1.73%	3.29%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-1.68%	0.32%	2.28%
Return on Equity (ROE)	0.00%	20.67%	10.67%	9.87%
Cash Return on Invested Capital (CROIC)	0.00%	-177.65%	13.74%	12.74%
Operating Return on Assets (OROA)	0.00%	9.65%	8.85%	6.71%
Return on Assets (ROA)	0.00%	7.56%	6.03%	3.85%
Return on Common Equity (ROCE)	0.00%	20.67%	10.67%	9.87%
Return on Equity Simple (ROE_SIMPLE)	0.00%	10.34%	14.84%	10.65%
Net Operating Profit after Tax (NOPAT)	2,074	2,094	1,909	1,340
NOPAT Margin	13.78%	14.01%	12.36%	8.67%
Net Nonoperating Expense Percent (NNEP)	0.00%	-4.83%	8.63%	4.29%
Return On Investment Capital (ROIC_SIMPLE)	-	10.48%	9.79%	7.33%
Cost of Revenue to Revenue	44.07%	44.58%	44.04%	42.03%
SG&A Expenses to Revenue	36.43%	37.68%	39.76%	40.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.53%	37.53%	39.70%	46.06%
Earnings before Interest and Taxes (EBIT)	2,925	2,637	2,440	1,793
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,656	3,281	3,067	2,415
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.19	3.50	4.23
Price to Tangible Book Value (P/TBV)	0.00	4.08	0.00	0.00
Price to Revenue (P/Rev)	0.25	0.25	2.54	2.64
Price to Earnings (P/E)	1.83	1.84	23.59	39.68
Dividend Yield	0.00%	0.00%	0.98%	3.80%
Earnings Yield	54.66%	54.29%	4.24%	2.52%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.14	2.55	2.81
Enterprise Value to Revenue (EV/Rev)	0.00	0.17	2.99	3.13
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.78	15.05	20.05
Enterprise Value to EBIT (EV/EBIT)	0.00	0.97	18.92	27.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	1.23	24.19	36.13
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	1.02	14.57	27.37
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	18.23	21.52
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.74	0.89
Long-Term Debt to Equity	0.00	0.00	0.69	0.73
Financial Leverage	0.00	-0.06	0.18	0.69
Leverage Ratio	0.00	1.37	1.77	2.56
Compound Leverage Factor	0.00	1.37	1.59	2.02
Debt to Total Capital	0.00%	0.00%	42.50%	47.10%
Short-Term Debt to Total Capital	0.00%	0.00%	3.07%	8.49%
Long-Term Debt to Total Capital	0.00%	0.00%	39.43%	38.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	57.50%	52.90%
Debt to EBITDA	0.00	0.00	2.70	3.56
Net Debt to EBITDA	0.00	0.00	2.25	3.12
Long-Term Debt to EBITDA	0.00	0.00	2.51	2.92
Debt to NOPAT	0.00	0.00	4.34	6.42
Net Debt to NOPAT	0.00	0.00	3.62	5.62
Long-Term Debt to NOPAT	0.00	0.00	4.03	5.26
Altman Z-Score	0.00	1.26	2.31	2.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	1.50	1.12	0.96
Quick Ratio	0.00	0.85	0.63	0.56
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-16,645	2,533	2,250
Operating Cash Flow to CapEx	153.21%	673.33%	675.48%	407.60%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.55	0.56	0.58
Accounts Receivable Turnover	0.00	7.05	7.36	7.29
Inventory Turnover	0.00	2.99	3.34	3.77
Fixed Asset Turnover	0.00	8.21	8.00	7.94
Accounts Payable Turnover	0.00	3.64	3.15	2.74
Days Sales Outstanding (DSO)	0.00	51.81	49.57	50.04
Days Inventory Outstanding (DIO)	0.00	121.90	109.40	96.70
Days Payable Outstanding (DPO)	0.00	100.16	115.87	133.25
Cash Conversion Cycle (CCC)	0.00	73.55	43.10	13.49
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	18,739	18,115	17,205
Invested Capital Turnover	0.00	1.60	0.84	0.88
Increase / (Decrease) in Invested Capital	0.00	18,739	-624	-910
Enterprise Value (EV)	0.00	2,571	46,162	48,411
Market Capitalization	3,802	3,802	39,258	40,874
Book Value per Share	$0.00	$11.64	$5.85	$5.04
Tangible Book Value per Share	$0.00	$0.54	($4.01)	($3.99)
Total Capital	0.00	19,970	19,497	18,275
Total Debt	0.00	0.00	8,286	8,607
Total Long-Term Debt	0.00	0.00	7,687	7,055
Net Debt	0.00	-1,231	6,904	7,537
Capital Expenditures (CapEx)	218	375	469	434
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	720	-126	268
Debt-free Net Working Capital (DFNWC)	0.00	1,951	1,256	1,338
Net Working Capital (NWC)	0.00	1,951	657	-214
Net Nonoperating Expense (NNE)	-3.55	30	245	310
Net Nonoperating Obligations (NNO)	0.00	-1,231	6,904	7,537
Total Depreciation and Amortization (D&A)	731	644	627	622
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	4.82%	-0.82%	1.73%
Debt-free Net Working Capital to Revenue	0.00%	13.05%	8.13%	8.66%
Net Working Capital to Revenue	0.00%	13.05%	4.25%	-1.38%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.90	$0.54
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	1.85B	1.92B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.90	$0.54
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	1.85B	1.92B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	1.91B	1.91B
Normalized Net Operating Profit after Tax (NOPAT)	2,074	2,103	1,909	1,895
Normalized NOPAT Margin	13.78%	14.07%	12.36%	12.26%
Pre Tax Income Margin	19.43%	17.64%	14.18%	9.16%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	46.03%	150.68%
Augmented Payout Ratio	0.00%	0.00%	46.45%	173.50%

This table displays calculated financial ratios and metrics derived from Kenvue's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	1/1/2023	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	3.33%	0.00%	1.09%	-0.27%	-0.41%	-0.11%	-3.93%	-4.03%
EBITDA Growth	0.00%	0.00%	0.00%	13.55%	277.71%	-11.94%	-64.52%	2.03%	-5.74%	2.53%	176.51%
EBIT Growth	0.00%	0.00%	0.00%	-7.18%	0.00%	-14.43%	-77.31%	-1.75%	-2.65%	5.75%	334.39%
NOPAT Growth	0.00%	0.00%	0.00%	-12.26%	0.00%	-22.64%	-70.91%	-18.34%	-2.93%	2.90%	259.70%
Net Income Growth	0.00%	0.00%	0.00%	-25.26%	0.00%	-36.89%	-86.51%	-12.56%	-10.40%	8.78%	624.14%
EPS Growth	0.00%	0.00%	0.00%	-32.35%	0.00%	-44.44%	-86.96%	-13.04%	-5.88%	13.33%	633.33%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	47.52%	-64.21%	-40.70%	-63.06%	-16.53%	49.13%	41.14%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	101.00%	26.18%	103.85%	99.24%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	-3.33%	0.00%	0.00%	1.44%	-5.02%	-1.59%	3.56%
Revenue Q/Q Growth	0.00%	0.00%	4.13%	-2.39%	-6.36%	6.22%	2.72%	-2.53%	-6.08%	2.16%	2.62%
EBITDA Q/Q Growth	-77.51%	359.04%	10.24%	-0.24%	-25.18%	7.02%	-55.59%	186.91%	-30.88%	16.41%	19.77%
EBIT Q/Q Growth	-100.00%	0.00%	13.44%	-1.01%	-33.87%	15.23%	-69.92%	328.66%	-34.47%	25.17%	23.55%
NOPAT Q/Q Growth	-100.00%	0.00%	-4.16%	12.53%	-20.74%	-9.51%	-63.96%	215.91%	-5.78%	-4.09%	26.00%
Net Income Q/Q Growth	0.00%	0.00%	-8.32%	1.86%	-25.34%	-9.48%	-80.41%	560.34%	-23.50%	9.90%	30.43%
EPS Q/Q Growth	0.00%	0.00%	-14.81%	0.00%	-26.09%	-11.76%	-80.00%	566.67%	-20.00%	6.25%	29.41%
Operating Cash Flow Q/Q Growth	0.00%	24.53%	-7.48%	-9.16%	40.95%	-69.79%	53.31%	-43.41%	218.47%	-46.03%	45.09%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	105.97%	-1,787.46%	0.77%	101.00%	653.25%	-48.50%	-119.68%
Invested Capital Q/Q Growth	0.00%	-100.00%	0.00%	0.00%	0.48%	-0.52%	-2.10%	3.66%	-5.92%	3.07%	3.02%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	55.17%	55.47%	57.47%	55.73%	57.58%	59.13%	58.53%	56.53%	57.95%	58.90%
EBITDA Margin	0.00%	19.78%	20.94%	21.40%	17.10%	17.23%	7.45%	21.93%	16.14%	18.39%	21.46%
Operating Margin	0.00%	16.61%	17.50%	18.14%	12.55%	14.12%	3.85%	16.77%	13.19%	14.92%	18.03%
EBIT Margin	0.00%	15.84%	17.25%	17.50%	12.36%	13.41%	3.93%	17.26%	12.04%	14.76%	17.77%
Profit (Net Income) Margin	0.00%	12.18%	10.72%	11.19%	8.92%	7.60%	1.45%	9.82%	8.00%	8.61%	10.94%
Tax Burden Percent	0.00%	77.01%	67.29%	74.87%	91.60%	69.32%	89.23%	66.38%	84.68%	70.31%	71.43%
Interest Burden Percent	0.00%	99.84%	92.34%	85.40%	78.81%	81.80%	41.40%	85.74%	78.46%	82.97%	86.22%
Effective Tax Rate	0.00%	22.99%	32.71%	25.13%	8.40%	30.68%	10.77%	33.62%	15.32%	29.69%	28.57%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	9.63%	16.83%	6.03%	9.48%	9.77%	8.98%	10.86%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	6.31%	14.52%	3.90%	8.79%	8.17%	8.04%	9.87%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	1.15%	10.12%	2.86%	6.03%	5.65%	5.87%	7.08%
Return on Equity (ROE)	0.00%	0.00%	0.00%	0.00%	10.78%	26.95%	8.89%	15.51%	15.42%	14.84%	17.94%
Cash Return on Invested Capital (CROIC)	-88.83%	0.00%	0.00%	0.00%	13.74%	-180.04%	-183.42%	6.04%	12.74%	9.16%	6.08%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	6.92%	15.22%	4.59%	9.88%	6.96%	8.43%	10.04%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	4.99%	8.63%	1.70%	5.62%	4.63%	4.92%	6.18%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	0.00%	10.78%	26.95%	8.89%	15.51%	15.42%	14.84%	17.94%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	14.04%	10.99%	10.00%	0.00%	10.50%	0.00%
Net Operating Profit after Tax (NOPAT)	0.00	493	472	532	421	381	137	434	409	392	494
NOPAT Margin	0.00%	12.80%	11.78%	13.58%	11.49%	9.79%	3.44%	11.13%	11.17%	10.49%	12.88%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	2.62%	3.33%	2.30%	2.13%	0.69%	1.61%	0.93%	0.99%
Return On Investment Capital (ROIC_SIMPLE)	0.00%	-	-	-	2.16%	-	-	-	2.24%	2.09%	2.56%
Cost of Revenue to Revenue	0.00%	44.83%	44.53%	42.53%	44.27%	42.42%	40.88%	41.47%	43.47%	42.05%	41.10%
SG&A Expenses to Revenue	0.00%	38.99%	37.95%	39.11%	43.26%	40.40%	41.03%	40.78%	41.64%	41.09%	39.18%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	38.55%	37.97%	39.34%	43.18%	43.45%	55.28%	41.75%	43.34%	43.04%	40.87%
Earnings before Interest and Taxes (EBIT)	0.00	610	692	685	453	522	157	673	441	552	682
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	166	762	840	838	627	671	298	855	591	688	824
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.19	0.00	0.00	0.00	3.50	3.79	3.39	4.19	4.23	4.51	3.74
Price to Tangible Book Value (P/TBV)	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.25	0.00	0.00	0.00	2.54	2.60	2.23	2.88	2.64	2.96	2.65
Price to Earnings (P/E)	1.84	0.00	0.00	0.00	23.59	27.01	30.81	41.87	39.68	42.89	28.27
Dividend Yield	0.00%	0.00%	0.00%	1.03%	0.98%	1.90%	3.33%	3.46%	3.80%	3.44%	3.93%
Earnings Yield	54.29%	0.00%	0.00%	0.00%	4.24%	3.70%	3.25%	2.39%	2.52%	2.33%	3.54%
Enterprise Value to Invested Capital (EV/IC)	0.14	0.00	0.00	0.00	2.55	2.65	2.38	2.85	2.81	2.99	2.61
Enterprise Value to Revenue (EV/Rev)	0.17	0.00	0.00	0.00	2.99	3.08	2.71	3.38	3.13	3.46	3.15
Enterprise Value to EBITDA (EV/EBITDA)	0.78	0.00	0.00	0.00	15.05	16.02	17.23	21.29	20.05	21.78	16.10
Enterprise Value to EBIT (EV/EBIT)	0.97	0.00	0.00	0.00	18.92	20.27	23.08	28.91	27.00	29.06	20.28
Enterprise Value to NOPAT (EV/NOPAT)	1.23	0.00	0.00	0.00	24.19	26.50	28.68	38.47	36.13	39.23	27.71
Enterprise Value to Operating Cash Flow (EV/OCF)	1.02	0.00	0.00	0.00	14.57	17.97	17.84	27.10	27.37	27.74	22.78
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	18.23	0.00	0.00	47.55	21.52	32.36	43.65
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.75	0.74	0.81	0.83	0.82	0.89	0.87	0.80
Long-Term Debt to Equity	0.00	0.00	0.00	0.71	0.69	0.66	0.69	0.66	0.73	0.63	0.66
Financial Leverage	-0.06	0.00	0.00	0.66	0.18	0.70	0.73	0.69	0.69	0.73	0.72
Leverage Ratio	1.37	0.00	0.00	2.49	1.77	2.57	2.60	2.51	2.56	2.59	2.56
Compound Leverage Factor	0.00	0.00	0.00	2.12	1.39	2.10	1.08	2.15	2.01	2.15	2.21
Debt to Total Capital	0.00%	0.00%	0.00%	42.94%	42.50%	44.61%	45.44%	44.98%	47.10%	46.50%	44.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	2.69%	3.07%	7.94%	7.65%	8.52%	8.49%	12.93%	8.03%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	40.25%	39.43%	36.68%	37.79%	36.46%	38.60%	33.57%	36.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	0.00%	0.00%	57.06%	57.50%	55.39%	54.58%	55.02%	52.90%	53.50%	55.48%
Debt to EBITDA	0.00	0.00	0.00	13.24	2.70	2.87	3.48	3.55	3.56	3.59	2.91
Net Debt to EBITDA	0.00	0.00	0.00	11.53	2.25	2.49	3.07	3.12	3.12	3.16	2.55
Long-Term Debt to EBITDA	0.00	0.00	0.00	12.42	2.51	2.36	2.90	2.88	2.92	2.59	2.39
Debt to NOPAT	0.00	0.00	0.00	0.00	4.34	4.76	5.80	6.41	6.42	6.47	5.01
Net Debt to NOPAT	0.00	0.00	0.00	0.00	3.62	4.11	5.10	5.64	5.62	5.69	4.39
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	4.03	3.91	4.82	5.20	5.26	4.67	4.11
Altman Z-Score	0.94	0.00	0.00	0.00	2.07	2.10	1.88	2.30	2.18	2.28	2.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.05%	0.00%	0.00%	0.00%	-0.02%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.50	0.00	0.00	1.14	1.12	0.99	0.99	1.00	0.96	0.86	0.98
Quick Ratio	0.85	0.00	0.00	0.61	0.63	0.54	0.55	0.58	0.56	0.51	0.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	-17,497	1,045	-17,640	-17,505	175	1,319	679	-134
Operating Cash Flow to CapEx	405.03%	1,956.10%	963.64%	591.23%	426.01%	187.58%	488.89%	422.03%	600.76%	239.11%	705.68%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	-185.68	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	802.00	0.00	0.00	0.00	3.02	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	761.00	0.00	0.00	0.00	1.41	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.00	0.00	0.00	0.56	1.14	1.17	0.57	0.58	0.57	0.57
Accounts Receivable Turnover	7.05	0.00	0.00	0.00	7.36	0.00	0.00	6.87	7.29	6.84	6.62
Inventory Turnover	2.99	0.00	0.00	0.00	3.34	0.00	0.00	3.52	3.77	3.60	3.51
Fixed Asset Turnover	8.21	0.00	0.00	0.00	8.00	0.00	0.00	8.48	7.94	7.78	7.49
Accounts Payable Turnover	3.64	0.00	0.00	0.00	3.15	0.00	0.00	2.87	2.74	2.60	2.54
Days Sales Outstanding (DSO)	51.81	0.00	0.00	0.00	49.57	0.00	0.00	53.16	50.04	53.34	55.10
Days Inventory Outstanding (DIO)	121.90	0.00	0.00	0.00	109.40	0.00	0.00	103.59	96.70	101.36	104.02
Days Payable Outstanding (DPO)	100.16	0.00	0.00	0.00	115.87	0.00	0.00	127.36	133.25	140.32	143.62
Cash Conversion Cycle (CCC)	73.55	0.00	0.00	0.00	43.10	0.00	0.00	29.39	13.49	14.37	15.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	18,739	0.00	0.00	18,029	18,115	18,021	17,642	18,288	17,205	17,734	18,270
Invested Capital Turnover	0.80	0.00	0.00	0.00	0.84	1.72	1.75	0.85	0.88	0.86	0.84
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	18,029	-624	18,021	17,642	259	-910	-287	628
Enterprise Value (EV)	2,571	3,802	0.00	0.00	46,162	47,666	41,941	52,191	48,411	52,977	47,628
Market Capitalization	3,802	3,802	0.00	0.00	39,258	40,266	34,477	44,547	40,874	45,296	40,088
Book Value per Share	$11.64	$0.00	$0.00	$5.69	$5.85	$5.55	$5.32	$5.56	$5.04	$5.26	$5.59
Tangible Book Value per Share	$0.54	$0.00	$0.00	($3.95)	($4.01)	($4.07)	($3.94)	($3.94)	($3.99)	($4.01)	($3.94)
Total Capital	19,970	0.00	0.00	19,091	19,497	19,176	18,656	19,345	18,275	18,791	19,340
Total Debt	0.00	0.00	0.00	8,198	8,286	8,555	8,478	8,701	8,607	8,738	8,610
Total Long-Term Debt	0.00	0.00	0.00	7,685	7,687	7,033	7,051	7,053	7,055	6,309	7,057
Net Debt	-1,231	0.00	0.00	7,136	6,904	7,400	7,464	7,644	7,537	7,681	7,540
Capital Expenditures (CapEx)	159	41	77	114	223	153	90	59	132	179	88
Debt-free, Cash-free Net Working Capital (DFCFNWC)	720	0.00	0.00	184	-126	298	357	586	268	416	349
Debt-free Net Working Capital (DFNWC)	1,951	0.00	0.00	1,246	1,256	1,453	1,371	1,643	1,338	1,473	1,419
Net Working Capital (NWC)	1,951	0.00	0.00	733	657	-69	-56	-5.00	-214	-956	-134
Net Nonoperating Expense (NNE)	0.00	24	42	94	94	85	79	51	116	70	74
Net Nonoperating Obligations (NNO)	-1,231	0.00	0.00	7,136	6,904	7,400	7,464	7,644	7,537	7,681	7,540
Total Depreciation and Amortization (D&A)	166	152	148	153	174	149	141	182	150	136	142
Debt-free, Cash-free Net Working Capital to Revenue	4.82%	0.00%	0.00%	0.00%	-0.82%	1.92%	2.31%	3.79%	1.73%	2.72%	2.31%
Debt-free Net Working Capital to Revenue	13.05%	0.00%	0.00%	0.00%	8.13%	9.38%	8.86%	10.63%	8.66%	9.63%	9.37%
Net Working Capital to Revenue	13.05%	0.00%	0.00%	0.00%	4.25%	-0.45%	-0.36%	-0.03%	-1.38%	-6.25%	-0.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.23	$0.17	$0.15	$0.03	$0.20	$0.16	$0.17	$0.22
Adjusted Weighted Average Basic Shares Outstanding	1.72B	0.00	0.00	1.92B	1.85B	1.92B	1.92B	1.92B	1.92B	1.91B	1.92B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.23	$0.17	$0.15	$0.03	$0.20	$0.16	$0.17	$0.22
Adjusted Weighted Average Diluted Shares Outstanding	1.72B	0.00	0.00	1.92B	1.85B	1.92B	1.92B	1.92B	1.92B	1.93B	1.93B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	1.91B	1.91B	1.91B	1.92B	1.92B	1.91B	1.92B	1.92B
Normalized Net Operating Profit after Tax (NOPAT)	0.00	493	472	532	421	410	635	455	464	434	537
Normalized NOPAT Margin	0.00%	12.80%	11.78%	13.58%	11.49%	10.52%	15.88%	11.66%	12.67%	11.61%	13.99%
Pre Tax Income Margin	0.00%	15.81%	15.93%	14.94%	9.74%	10.97%	1.63%	14.80%	9.45%	12.24%	15.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	610.00	0.00	0.00	0.00	5.49	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	492.87	0.00	0.00	0.00	4.01	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	569.00	0.00	0.00	0.00	3.88	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	451.87	0.00	0.00	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	46.03%	77.06%	136.91%	144.92%	150.68%	147.82%	110.79%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	46.45%	77.06%	136.91%	144.92%	173.50%	167.42%	129.90%

Key Financial Trends

Kenvue Inc. (NYSE: KVUE) has demonstrated solid financial performance over the past four years, with notable growth in revenue and net income.

Revenue growth: Operating revenue increased from about $3.85 billion in Q1 2023 to nearly $3.84 billion in Q2 2025, showing stable demand for products over the period.
Net income improvement: Consolidated net income rose significantly from approximately $469 million in Q1 2023 to $420 million in Q2 2025, indicating improved profitability.
Gross profit margin: Gross profit remained robust, with total gross profit near $2.26 billion in Q2 2025, up from roughly $2.12 billion in Q1 2023, reflecting effective cost management.
Consistent operating cash flow: Net cash from operating activities stayed positive and strong, with $621 million in Q2 2025, supporting healthy liquidity and operational efficiency.
Strong equity base: Total common equity increased from about $10.6 billion in Q1 2023 to over $10.7 billion in Q2 2025, demonstrating a stable financial foundation.
Managing restructuring and operating expenses: Restructuring charges remained present (e.g., $60 million in Q2 2025), but relatively stable, showing ongoing cost optimization efforts.
Capital expenditures: Kenvue consistently invested in property, plant, and equipment, with around $88 million spent in Q2 2025, indicating commitment to growth but potentially limiting free cash flow temporarily.
Slight increase in liabilities: Total liabilities grew to about $16.4 billion in Q2 2025 from approximately $16.2 billion in Q1 2023, a manageable increase linked to business expansion.
Decrease in accumulated other comprehensive income/loss: Accumulated other comprehensive loss remained significant at around -$5 billion in Q2 2025, potentially impacting overall equity quality.
Increasing interest and other expenses: Total other income/(expense) showed a consistent net expense (e.g., -$104 million in Q2 2025), which may pressure net income if not controlled.

Summary: Kenvue has steadily grown its revenues and profitability over the last four years, supported by a strong equity base and healthy cash flows from operations. The company has managed costs and restructuring expenses effectively while investing in capital assets. However, attention should be paid to ongoing comprehensive loss and other expenses that could impact future earnings quality. Overall, Kenvue's financial health appears solid with positive trends supporting its stock.

08/09/25 04:15 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Kenvue's Financials

When does Kenvue's financial year end?

According to the most recent income statement we have on file, Kenvue's fiscal year ends in December. Their fiscal year 2024 ended on December 29, 2024.

How has Kenvue's net income changed over the last 3 years?

Kenvue's net income appears to be on a downward trend, with a most recent value of $1.03 billion in 2024, falling from $2.08 billion in 2021. The previous period was $1.66 billion in 2023. See where experts think Kenvue is headed by visiting Kenvue's forecast page.

What is Kenvue's operating income?

Kenvue's total operating income in 2024 was $1.84 billion, based on the following breakdown:

Total Gross Profit: $8.96 billion
Total Operating Expenses: $7.12 billion

How has Kenvue's revenue changed over the last 3 years?

Over the last 3 years, Kenvue's total revenue changed from $15.05 billion in 2021 to $15.46 billion in 2024, a change of 2.7%.

How much debt does Kenvue have?

Kenvue's total liabilities were at $15.93 billion at the end of 2024, a 4.2% decrease from 2023, and a 116.9% increase since 2022.

How much cash does Kenvue have?

In the past 2 years, Kenvue's cash and equivalents has ranged from $1.07 billion in 2024 to $1.38 billion in 2023, and is currently $1.07 billion as of their latest financial filing in 2024.

How has Kenvue's book value per share changed over the last 3 years?

Over the last 3 years, Kenvue's book value per share changed from 0.00 in 2021 to 5.04 in 2024, a change of 504.3%.

Related Companies

This page (NYSE:KVUE) was last updated on 8/9/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kenvue (KVUE) Financials

Key Financial Trends

Frequently Asked Questions About Kenvue's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kenvue (KVUE) Financials

Annual Income Statements for Kenvue

Quarterly Income Statements for Kenvue

Annual Cash Flow Statements for Kenvue

Quarterly Cash Flow Statements for Kenvue

Annual Balance Sheets for Kenvue

Quarterly Balance Sheets for Kenvue

Annual Metrics And Ratios for Kenvue

Quarterly Metrics And Ratios for Kenvue

Key Financial Trends

Frequently Asked Questions About Kenvue's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools